Government News

- Read more about CDSCO held meeting on introducing ‘trace and track’ mechanism for top 300 brands
The Central Drugs Standard Control Organisation (CDSCO) has taken step to introduce an effective “trace and track” mechanism on top 300 brands, which would be included in the initiative. The top 300 brands were identified on the basis of moving annual total (MAT) data.
- Read more about Importance of India and Africa Strategic Partnerships to Build Health Innovations for Universal Health Coverage (UHC)
In an endeavour to encourage health innovations in India and Africa, a conclave was organised by the Public Health Foundation of India (PHFI), Amref Africa, the Institute of Development Studies, UK (IDS UK), Indian Institute of Public Health Gandhinagar in partnership with NITI Aayog. This event was hosted at the GE Healthcare Centre in Bengaluru.
- Read more about NIH plans to end funding for Moderate Alcohol and Cardiovascular Health trial
The National Institutes of Health plans to end funding to Moderate Alcohol and Cardiovascular Health (MACH) trial. National Institute of Alcohol Abuse and Alcoholism (NIAAA) funding for the MACH trial will end within the next few months following completion of an orderly closeout.
- Read more about Separate rack for generic medicines in retail shop
The central government has ordered pharmacies to display generic drugs on separate shelves so that consumers can opt for generic medicine to expensive brand name drugs.
Drug Comptroller General has issued a letter to all states and union territories to provide a shelf for display of generic medicines.

[adsense:336x280:8701650588]
- Read more about WHO publish list of essential diagnostic tests to improve diagnosis
WHO published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases.
- Read more about IORA-RCSTT Coordination Centre on Medicinal Plants Inaugurated at CSIR-CIMAP, Lucknow
The Indian Ocean Rim Association - Regional Centre for Science and Technology Transfer (IORA-RCSTT) Coordination Centre was inaugurated on 7 May 2018 at the Central Institute of Medicinal and Aromatic Plants (CIMAP) campus of the Council of Scientific and Industrial Research (CSIR) in Lucknow.

[adsense:336x280:8701650588]
- Read more about ICMR Issue latest guidelines for management of type 2 diabetes
The International Diabetes Federation (IDF) estimates that there are 72.9 million
people with diabetes in India in 2017, which is projected to rise to 134.3 million by the
year 2045. The prevalence of diabetes in urban India, especially in large metropolitan
cities has increased from 2% in the 1970s to over 20% at present and the rural areas
are also fast catching up.
- Read more about Central Government strengthens TB cure by making obligatory action from doctors and pharmacists to submit complete info on tuberculosis patients
Government takes obligatory action for collecting data of all tuberculosis patients to ensure proper tuberculosis diagnosis and its management in patients and their contacts and to reduce tuberculosis transmission and further to address the problems of emergence and spread of Drug Resistant-Tuberculosis.
- Read more about Government push pain killer Tramadol under narcotics laws
Government of India brings Tramadol, a synthetic opioid pain killer, under the control of the Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985. Tramadol is also known as ISIS Drug. ISIS militants are known to abuse tramadol to suppress pain and boost strength during injury. International anti-narcotics authorities also called it as fighter drug.
- Read more about Indian Patent act need revisions, requests Indian and Foreign pharmaceutical associations
Indian and foreign pharmaceutical associations need amendment in section 146 of Indian patent act 1970 and form 27 for making Indian patenting system more efficient and it will eliminate vague and unnecessary annual working statement disclosures. Indian patent office has invited responses from stake holders and many pharmaceutical industries and association responded in this regards.